ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012